NEMA Research, Inc., Naples, FL, USA.
NEMA Research, Inc., Naples, FL, USA -
Minerva Anestesiol. 2019 Aug;85(8):899-908. doi: 10.23736/S0375-9393.19.13321-4. Epub 2019 Mar 12.
Healthcare professionals and organizations increasingly face the conundrum of treating patients with active substance use disorder, a history of personal or familial substance use disorder, or those at elevated risk for substance abuse. Such patients need compassionate care when facing painful conditions; in fact, denying them pain control makes it likely that they will seek out ways to self-medicate with illicit drugs. Yet it remains unclear how to safely and effectively treat patients in these challenging situations. The authors have formulated ten questions to address in order to provide adequate analgesia for such patients. These questions demand a highly individualized approach to analgesia. These ten questions involve understanding the painful condition (presumed trajectory, duration, type of pain), using validated metrics such as risk assessment tools, guidelines, protocols, and safeguards within the system, selection of the optimal analgesic product(s) or combination therapy, and never starting opioid therapy without clear treatment objectives and a definitive exit plan. It is tempting but inaccurate to label these individuals as "inappropriate patients," rather they are high-risk individuals in very challenging clinical situations. The challenge is that both options - being in pain or being treated with opioids to control pain - expose the patient to a risk of rekindling an addiction. The question is how do we, as clinicians, adequately respond to these very perplexing clinical challenges?
治疗有物质使用障碍、个人或家族物质使用障碍史或有物质滥用高风险的患者。当这些患者面临痛苦的病情时,他们需要得到富有同情心的护理;事实上,拒绝为他们提供疼痛控制很可能会导致他们寻求非法药物来自我治疗。然而,目前仍不清楚如何在这些具有挑战性的情况下安全有效地治疗这些患者。作者提出了十个问题,以提供足够的镇痛治疗。这些问题需要对镇痛进行高度个体化的治疗。这十个问题涉及了解疼痛情况(假定的轨迹、持续时间、疼痛类型),使用风险评估工具等经过验证的指标,系统内的指南、方案和保障措施,选择最佳的镇痛产品或联合治疗,并且在没有明确的治疗目标和明确的退出计划的情况下,切勿开始阿片类药物治疗。将这些患者贴上“不适当患者”的标签是诱人的,但却是不准确的,他们是处于非常具有挑战性的临床情况下的高风险个体。挑战在于,无论是处于疼痛状态还是用阿片类药物来控制疼痛,都会使患者面临重新上瘾的风险。问题是,作为临床医生,我们如何应对这些非常令人困惑的临床挑战?